To determine how tetraspanin KAI1/CD82, a tumor metastasis suppressor, inhibits cell migration, we assessed which cellular events critical for motility are altered by KAI1/CD82 and how KAI1/CD82 regulates these events. We found that KAI1/CD82-expressing cells typically exhibited elongated cellular tails and diminished lamellipodia. Live imaging demonstrated that the polarized protrusion and retraction of the plasma membrane became deficient upon KAI1/CD82 expression. The deficiency in developing these motility-related cellular events was caused by poor formations of actin cortical network and stress fiber and by aberrant dynamics in actin organization. Rac1 activity was reduced by KAI1/CD82, consistent with the diminution of lamellipodia an...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
KAI1/CD82, a tetraspanin protein, was first identified as a metastasis suppressor in prostate cancer...
KAI1/CD82, a tetraspanin protein, was first identified as a metastasis suppressor in prostate cancer...
<div><p>To determine how tetraspanin KAI1/CD82, a tumor metastasis suppressor, inhibits cell migrati...
To determine how tetraspanin KAI1/CD82, a tumor metastasis suppressor, inhibits cell migration, we a...
To determine how tetraspanin KAI1/CD82, a tumor metastasis suppressor, inhibits cell migration, we a...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
The plasma membrane is a key actor of cell migration. For instance, its tension controls persistent ...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
KAI1/CD82, a tetraspanin protein, was first identified as a metastasis suppressor in prostate cancer...
KAI1/CD82, a tetraspanin protein, was first identified as a metastasis suppressor in prostate cancer...
<div><p>To determine how tetraspanin KAI1/CD82, a tumor metastasis suppressor, inhibits cell migrati...
To determine how tetraspanin KAI1/CD82, a tumor metastasis suppressor, inhibits cell migration, we a...
To determine how tetraspanin KAI1/CD82, a tumor metastasis suppressor, inhibits cell migration, we a...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
The plasma membrane is a key actor of cell migration. For instance, its tension controls persistent ...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
International audienceThe plasma membrane is a key actor of cell migration. For instance, its tensio...
KAI1/CD82, a tetraspanin protein, was first identified as a metastasis suppressor in prostate cancer...
KAI1/CD82, a tetraspanin protein, was first identified as a metastasis suppressor in prostate cancer...